Skip to main content
. 2014 Aug 30;14:638. doi: 10.1186/1471-2407-14-638

Table 1.

Clinical and histopathological information for each patient used for gene expression profiling

Patient Gender T-stage N status Relapse Dead of Bladder cancer Time to relapse (months) Follow up (months)
2211 Man 4a Positive No No 24
1599 Woman 1 Positive No No 22
2114 Man 3b Positive Yes Yes 9 61
2117 Man 3b Positive No No 11
2130 Man 1 Positive Yes Yes 14 16
2163 Man 2 Positive No No 65
2180 Man 3 Positive Yes Yes 18 30
2207 Man 4a Positive Yes Yes 9 22
2249 Woman 1 Positive Yes Yes 3 13
2237 Woman 2 Positive No No 31
1956 Man 1 Negative No No 66
1930 Man 1 Negative No No 61
1940 Woman 2 Negative No No 61
1743 Man 1 Negative Yes Yes 40 57
2036 Man 2 Negative No No 77
1874 Man 3b Negative No No 63
1607 Woman 2 Negative No No 60
1956 Man 1 Negative No No 61